Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Rebranding? Here’s How to Communicate With Investors
    A corporate rebranding is generally done with potential customers in mind. But it’s crucial to also consider investors when communicating about it. The post Rebranding? Here’s How to Communicate With Investors appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • MiFID II: New EU Regulations Will Have a Huge Global Impact
    The new EU financial markets regulation MiFID II will have a huge global impact on the research landscape. Here’s how it could affect every public company. The post MiFID II: New EU Regulations Will Have a Huge Global Impact appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Are There Reasons for Optimism in the Healthcare IPO Market?
    After a lengthy retrenchment, renewed interest in healthcare IPOs has emerged. Are we on the cusp of a revitalized IPO market? Our experts weigh in. The post Are There Reasons for Optimism in the Healthcare IPO Market? appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • What to Consider When Choosing a Data Room
    Here are some things to consider when it’s time to choose a data room for sharing sensitive information with investors and analysts. The post What to Consider When Choosing a Data Room appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Five Don’ts for an Investor Meeting Over Lunch
    Investor meetings are usually pressure-filled, even when you’re meeting for a “casual” lunch. Here are five things don’ts for these meetings. The post Five Don’ts for an Investor Meeting Over Lunch appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Biotech Investor Relations: Six Burning Questions Answered
    In biotech, investor relations is a constant concern. Here are answers to six common IR questions, like why it’s tough to meet with the buy side right now. The post Biotech Investor Relations: Six Burning Questions Answered appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Life Sciences Capital Markets: Insight From Two Experts
    What is the outlook for the life sciences capital markets for the rest of 2017 and beyond? It depends on several factors, according to our experts. The post Life Sciences Capital Markets: Insight From Two Experts appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Six Ways to Make the Most of Dinner with a Research Analyst
    ing with a research analyst should be a positive experience for you and your company, not a nerve-racking disaster. Here’s how to get it right. The post Six Ways to Make the Most of Dinner with a Research Analyst appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Six Do’s and Don’ts for Managing Investor Expectations
    Managing investor expectations is vital for protecting your share price. Here are six do’s and don’ts for communicating more effectively with The Street. The post Six Do’s and Don’ts for Managing Investor Expectations appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • How to Deal With That One Difficult Research Analyst
    Executives cannot afford to retaliate against a research analyst who dislikes their company. Here’s how to change minds and mend relationships. The post How to Deal With That One Difficult Research Analyst appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • What to Do When An Investor Meeting Goes Awry
    There are plenty of reasons that an investor meeting can go badly, from sleeping investors to misbehaving executives. Here’s to ensure yours go smoothly. The post What to Do When An Investor Meeting Goes Awry appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Four Considerations For Your Non-Deal Road Show Strategy
    Non-deal road shows are a great way to drum up new investors and highlight your company’s story. But it’s important to think strategically. The post Four Considerations For Your Non-Deal Road Show Strategy appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Answering Investors’ Awkward Questions: Stick to the Script
    Business success and regulatory compliance can depend on how executives respond to the seemingly awkward questions posed by the investment community. The post Answering Investors’ Awkward Questions: Stick to the Script appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Why Your Corporate Bench Strength Matters to Investors
    However talented your CEO and CFO are, investors want to know about your other key executives. Here’s how to communicate about your bench strength. The post Why Your Corporate Bench Strength Matters to Investors appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Scared of Hedge Funds? Here’s Why You Shouldn’t Be
    Corporate managers should reconsider their reluctance to meet with hedge funds for fear of triggering short positions. There are benefits to be had. The post Scared of Hedge Funds? Here’s Why You Shouldn’t Be appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • Four Tips for Managing Your Quarterly Quiet Period
    The quarterly quiet period can free managers to complete earnings-related work, but be sure to follow these four tips for managing them correctly. The post Four Tips for Managing Your Quarterly Quiet Period appeared first on Westwicke Partners.
  • What We Learned at J.P. Morgan 2017
    What were the key insights from the expert healthcare investors attending J.P. Morgan 2017? Here’s what our team learned in San Francisco. The post What We Learned at J.P. Morgan 2017 appeared first on Westwicke Partners.
  • Five Tips for Raising Capital Pre-IPO or Acquisition
    A pre-IPO healthcare company often needs to raise private capital. These tips will help you strike the best deal for your firm. The post Five Tips for Raising Capital Pre-IPO or Acquisition appeared first on Westwicke Partners.
  • What Public Company CEOs, CFOs Need to Know About After-Hours Trading
    After-hours trading is a source of confusion for many CEOs and CFOs. We asked America’s newest stock exchange, IEX, to explain how it works. The post What Public Company CEOs, CFOs Need to Know About After-Hours Trading appeared first on Westwicke Partners.
  • Tips for Building a Better Investor Relations Plan
    To succeed on Wall Street, companies need a high-quality investor relations plan that avoids or corrects the mistakes that so many others make. The post Tips for Building a Better Investor Relations Plan appeared first on Westwicke Partners.
  • Our Most Well-Read Investor Relations Posts of 2016
    Healthcare stocks have endured a challenging 2016. Here’s a look at some of our most popular posts of the year, as executives navigated choppy waters. The post Our Most Well-Read Investor Relations Posts of 2016 appeared first on Westwicke Partners.
  • Seven Tips to Help Ensure Successful Biotech Earnings Calls
    Pre-revenue biotech companies have few opportunities to share news with analysts. Here’s advice to get the most out of your earnings calls. The post Seven Tips to Help Ensure Successful Biotech Earnings Calls appeared first on Westwicke Partners.
  • Life for a Life Sciences Investor Relations Officer: Double Duty
    Investor relations officers with life sciences companies have a uniquely challenging role: understanding the strategy and the science. The post Life for a Life Sciences Investor Relations Officer: Double Duty appeared first on Westwicke Partners.
  • Why Private Companies Should Meet the Buy Side Early
    Private, VC-backed companies should lay the groundwork with institutional buy-side investors well before the IPO road show. The post Why Private Companies Should Meet the Buy Side Early appeared first on Westwicke Partners.
  • How to Engage with Sell-Side Analysts: Tips from the Source
    We invited two sell-side analysts to explain how healthcare company management teams can work better with them. Here’s what they said. The post How to Engage with Sell-Side Analysts: Tips from the Source appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

New blog articles detected.

  • To Be Ready for J.P. Morgan 2017, Do These 9 Things Now
    Have you started your planning for the 2017 J.P. Morgan Healthcare conference? If not, you’d better get started. Here’s what you should be doing right now. The post To Be Ready for J.P. Morgan 2017, Do These 9 Things Now appeared first on Westwicke Partners.
Westwicke Partners, LLC
Westwicke Partners, LLC
Blog Post

Out-Market Your Competitors?

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account Log in

By signing up, you agree to the Terms of Service and Privacy Policy.

Out-Market Your Competitors

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account

Already a user?  Log in

By signing up, you agree to the Terms of Service and Privacy Policy.